Ironwood製藥 IRWD 深 滬
已收盤 09-05 16:00:00 美东时间
1.155
+0.055
+5.00%
華盛通- 最 高1.16
- 今 開1.07
- 成交量 85.88万股
- 最 低 1.07
- 昨 收 1.10
- 總市值 1.87亿
- 52周最高 5.1288
- 市盈率 靜 210.00
- 換手率 0.53%
- 52周最低 0.5271
- 委 比 8.29%
- 總股本 1.62亿
- 歷史最高 18.915
- 量 比 0.53
- 振 幅 8.18%
- 歷史最低 0.5271
- 每 手 1
- 風險率 3.14%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Why American Eagle Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket
Shares of American Eagle Outfitters, Inc. (NYSE:AEO) rose sharply in pre-market...
09-04 17:42
Ironwood Pharmaceuticals shares are trading higher after the company reported better-than-expected Q2 financial results and issued FY25 sales guidance with its midpoint above estimates.
Ironwood Pharmaceuticals shares are trading higher after the company reported b...
08-07 22:47
Ironwood Pharmaceuticals Sees FY2025 Sales $260.000M-$290.000M vs $270.600M Est
Ironwood Pharmaceuticals (NASDAQ:IRWD) sees FY2025 sales of $260.000 million-$290.000 million vs $270.600 million analyst estimate.
08-07 19:25
Ironwood Pharmaceuticals Q2 Adj. EPS $0.14 Beats $0.04 Estimate, Sales $85.239M Beat $60.775M Estimate
Ironwood Pharmaceuticals (NASDAQ:IRWD) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.04 by 250 percent. This is a 1300 percent increase over earnings of $0.01 per share
08-07 19:20
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Ironwood Pharmaceuticals (NASDAQ:IRWD) stock rose 15.2% to $0.71 durin...
06-14 05:05
美股大行评级 | 潜在涨幅684.71%！Verve Therapeutics获Canaccord Genuity升目标价至39美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1119185980869894144.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Canaccord Genuity：维持Verve Therapeutics(VERV)"买入"评级，目标价从32美元升至39美元</p> <p>• HC Wainwright & Co.：维持Verve Ther
04-16 09:45
Trump targets Medicare price negotiations in new executive order
President Donald Trump on Tuesday signed an executive order to lower prescription drug prices through a series of measures, including a requirement to change a key provision in the Medicare drug price...
04-16 08:23
Ironwood downgraded at Jefferies on apraglutide-related challenges
Ironwood Pharmaceuticals (NASDAQ:IRWD) has been downgraded to Hold from Buy at Jefferies after the company announced pressures related to its lead asset, apraglutide. The company announced Monday tha...
04-16 00:10
Jefferies Downgrades Ironwood Pharmaceuticals to Hold, Lowers Price Target to $0.7
Jefferies analyst Amy Li downgrades Ironwood Pharmaceuticals (NASDAQ:IRWD) from Buy to Hold and lowers the price target from $8 to $0.7.
04-15 19:50
